Hyaluronan inhibits matrix metalloproteinase‐13 in human arthritic chondrocytes via CD44 and P38
Open Access
- 12 August 2010
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 29 (2) , 258-264
Abstract
We investigated the effects of hyaluronan (HA) on interleukin‐1β (IL‐1β)‐stimulated matrix metalloproteinase (MMP)‐13 production in human chondrocytes from patients with osteoarthritis (OA) or rheumatoid arthritis (RA). Secreted levels of MMP‐13 in conditioned media were detected by immunoblotting, while intracellular MMP‐13 synthesis in articular cartilage was evaluated by immunofluorescence microscopic analysis. Mitogen‐activated protein kinases (MAPKs), p38, extracellular signal‐regulated kinases (ERK), and c‐jun NH2‐terminal kinase (JNK) were assessed by Western blotting. IL‐1β (2 ng/ml) stimulates the secretion of MMP‐13 in both OA and RA chondrocytes. Inhibition studies using specific MAPK inhibitors revealed that IL‐1β induced MMP‐13 via p38 in both OA and RA chondrocytes. HA down‐regulates IL‐1β‐stimulated MMP‐13 and phosphorylated p38 (p‐p38) in a dose‐dependent manner (0.1, 1, 2, and 4 mg/ml). When used at 4 mg/ml, HA inhibits p‐p38 phosphorylation by more than 60%. In response to IL‐1β, RA chondrocytes express a higher level of p‐p38 than that of OA chondrocytes. Inhibition of CD44, using a blocking antibody, significantly reversed the inhibitory effect of HA on both MMP‐13 and p‐p38. Our study clearly shows that HA inhibits IL‐1β‐induced MMP‐13 via its principal receptor, CD44, and subsequent intracellular p38 MAPK signaling in OA and RA chondrocytes. © 2010 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 29:258–264, 2011Keywords
This publication has 37 references indexed in Scilit:
- Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activityOsteoarthritis and Cartilage, 2005
- Therapeutic Effects of Hyaluronic Acid on Osteoarthritis of the KneeJournal of Bone and Joint Surgery, 2004
- Intra-articular Hyaluronic Acid in Treatment of Knee OsteoarthritisJAMA, 2003
- Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-jun N-terminal kinase, and nuclear factor κB: Differential regulation of collagenase 1 and collagenase 3Arthritis & Rheumatism, 2000
- Collagenase‐3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ. In vitro mimicking effect by transforming growth factor βArthritis & Rheumatism, 1997
- Hyaluronan: its nature, distribution, functions and turnoverJournal of Internal Medicine, 1997
- Structural Analysis and Promoter Characterization of the Human Collagenase-3 Gene (MMP13)Genomics, 1997
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy.Annals of the Rheumatic Diseases, 1994
- Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbitExperimental Physiology, 1991